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Background. Chest radiographs (CXRs) are a valuable diagnostic tool in epidemiologic studies of pneumonia. The World Health 
Organization (WHO) methodology for the interpretation of pediatric CXRs has not been evaluated beyond its intended application 
as an endpoint measure for bacterial vaccine trials.
Methods. The Pneumonia Etiology Research for Child Health (PERCH) study enrolled children aged 1–59 months hospital-
ized with WHO-defined severe and very severe pneumonia from 7 low- and middle-income countries. An interpretation process 
categorized each CXR into 1 of 5 conclusions: consolidation, other infiltrate, both consolidation and other infiltrate, normal, or 
uninterpretable. Two members of a 14-person reading panel, who had undertaken training and standardization in CXR interpreta-
tion, interpreted each CXR. Two members of an arbitration panel provided additional independent reviews of CXRs with discordant 
interpretations at the primary reading, blinded to previous reports. Further discordance was resolved with consensus discussion.
Results. A total of 4172 CXRs were obtained from 4232 cases. Observed agreement for detecting consolidation (with or without 
other infiltrate) between primary readers was 78% (κ = 0.50) and between arbitrators was 84% (κ = 0.61); agreement for primary 
readers and arbitrators across 5 conclusion categories was 43.5% (κ = 0.25) and 48.5% (κ = 0.32), respectively. Disagreement was 
most frequent between conclusions of other infiltrate and normal for both the reading panel and the arbitration panel (32% and 30% 
of discordant CXRs, respectively).
Conclusions. Agreement was similar to that of previous evaluations using the WHO methodology for detecting consolidation, 
but poor for other infiltrates despite attempts at a rigorous standardization process.
Keywords. observer variation; chest radiograph; pneumonia; pediatrics; diagnosis.
 
The chest radiograph (CXR) is a valuable diagnostic tool for 
pneumonia, both as part of clinical management [1] and for 
determining case status in epidemiological studies [2]. CXRs 
can be archived and systematically evaluated, enabling cross-
study comparisons. However, CXR interpretations are sub-
jective, making it difficult to achieve measurements that are 
reproducible, reliable, and valid [3–5]. Acknowledging this, 
the World Health Organization (WHO) developed a standard-
ized methodology for the interpretation of pediatric CXRs (the 
“WHO methodology”), designed to optimize the identification 
of Streptococcus pneumoniae and Haemophilus influenzae type 
b (Hib) pneumonia in vaccine trials [2, 6]. The WHO meth-
odology has since been adopted by many studies of vaccine 
efficacy and effectiveness [7–11], a trial of indoor air pollution 
reduction [12], incidence and surveillance studies [13–15], and 
descriptive epidemiology of pneumonia cases [16, 17]. Despite 
widespread use, there has been no evaluation of how best to 
implement the WHO methodology, especially beyond its initial 
application in vaccine trials.
Here we describe the process for CXR interpretation in a 
large childhood pneumonia study, evaluate the standardization 
of readers and observer variability, and assess the process of 
arbitration for discordant interpretations.
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METHODS
Data Collection
Pneumonia Etiology Research for Child Health (PERCH) 
is a multicountry, standardized, case-control study of the 
causes and risk factors of childhood pneumonia [18]. A total 
of 4232 cases of hospitalized, WHO-defined severe or very 
severe pneumonia in children aged 1–59 months were enrolled 
from August 2011 to January 2014. Nine sites in 7 countries 
were chosen to be representative of the epidemiological con-
texts where pneumonia is most prevalent: Dhaka and Matlab, 
Bangladesh; Basse, The Gambia; Kilifi, Kenya; Bamako, Mali; 
Soweto, South Africa; Nakhon Phanom and Sa Kaeo, Thailand; 
and Lusaka, Zambia. The institutional review board or ethical 
review committee approved the study protocol at each of the 
7 institutions and at the Johns Hopkins Bloomberg School of 
Public Health. Parents or guardians of participants provided 
written informed consent.
A CXR was sought from each case as soon as practical after 
clinical evaluation and study enrollment; some children had 
repeat CXRs if clinically indicated. In cases where a CXR was 
not obtained, the reason was recorded. All CXRs were taken 
in either anterior-posterior or posterior-anterior format 
as required by the WHO methodology [2]. Most sites used 
digital CXR imaging equipment, except Zambia and Matlab 
where analog techniques were used. The Gambian site used 
an analog machine when there were technical problems with 
their digital system. At Nakhon Phanom and South Africa, 
analog CXRs were performed for 11 and 8  months, respec-
tively, before digital systems were installed. All analog images 
were scanned into digital format [19]. All sites were assessed 
as meeting quality and safety requirements prior to study 
enrollment.
Chest Radiograph Interpretation
Two members from each of the 7 study sites (5 radiolo-
gists and 9 pediatricians with 0–28 years postspecialization 
experience) formed the CXR reading panel. Four additional 
radiologists (3 with extensive WHO methodology experi-
ence) from Australia, Kenya, and the United Kingdom 
formed an arbitration panel to interpret CXRs discordant 
at the initial interpretation, and ensured consistency to pre-
vious studies by using a common arbitration process [2]. 
Members of the arbitration panel also provided a 2-day, 
in-person training workshop for the reading panel. To 
ensure this training was optimized for PERCH, the arbitra-
tion panel met first to calibrate the application of the WHO 
definitions to PERCH CXRs. Three members of the read-
ing panel who were unable to attend the training viewed 
recorded lectures and met with another member of the 
reading panel to review key concepts. Prior to interpreting 
PERCH study CXRs, all readers were assessed by interpret-
ing 20 randomly selected WHO reference CXRs. Readers 
were required to correctly identify the reference conclusion 
for ≥50% of all images, ≥66% of images with consolidation, 
and ≥66% of normal images. Repeat training and assess-
ment with additional sets of 20 images was performed until 
standardization was achieved. Continuing education was 
provided through monthly emails that reviewed key teach-
ing points, and a voluntary reassessment with the first set 
of 20 WHO images.
Figure 1 shows the process for interpretation of CXRs. 
Arbitrators were blinded to previous conclusions except at 
final consensus discussions. Table 1 shows the classification 
of findings, conclusions derived from these findings, and the 
arbitration process used [6]. The WHO methodology was 
optimized for “any consolidation” (also termed “primary 
endpoint pneumonia” as a specific reference to the out-
come of interest in vaccine trials) and thus this conclusion 
is frequently evaluated. Also outlined in Table 1 are alter-
nate conclusions and arbitration processes used to evaluate 
the effects of 4 different interpretation methods on observer 
agreement, the distribution of conclusions, and the number 
of interpretations required.
Analysis
We assessed agreement for the primary reading and arbitration 
panels, as well as separately for each member of the primary 
reading panel. Observer agreement was evaluated by observed 
percentage agreement and the kappa statistic (κ), which pro-
vides a measure of agreement adjusted for chance agreement 
[20]. Fleiss’ κ was used for interobserver calculations because 
PERCH used randomized reader-pairs rather than observers 
with a constant identity across interpretations [20]. Cohen’s κ 
was used for intraobserver assessment of repeat standardization 
Figure 1. Interpretation process for chest radiographs (CXRs) in the Pneumonia 
Etiology Research for Child Health (PERCH) project. aArbitration results for quality 
control images were not used to determine the final conclusion. bFinal conclusion 
represents the conclusion reached for each of the 4172 CXRs and not the distribu-
tion of CXR diagnoses for the 4232 enrolled cases as some cases have multiple 
CXRs interpreted and some missing.
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assessments, and for interobserver calculations for individual 
conclusions to allow calculation of confidence intervals. For 
analyses of individual conclusions, a κ adjusted for prevalence 
and differences in each reader’s distribution of findings (also 
known as marginal distributions) was also calculated [21, 22]. 
Because uninterpretable images are assumed to be a conse-
quence of the imaging process and image quality may contribute 
to variability in interpretation, for some analyses images with 
one or more interpretations of uninterpretable are excluded, as 
is common in evaluating observer agreement for CXRs [3, 6]. 
The χ2 goodness-of-fit test was used to assess the distribution 
of final arbitration discussion conclusions that agreed with each 
arbitrator’s initial interpretation, using equal proportions (25%) 
as expected values.
Data exploration and analyses were completed using Stata 
software version 12.1 (StataCorp, College Station, Texas).
Table 1. Classification of Findings and Conclusions for the Standardized Interpretation of Chest Radiographs
Classification Definition
Findings (adapted from Cherian et al [6]) Consolidationa A dense or fluffy opacity that occupies a portion or whole of a lobe or of the 
entire lung that may or may not contain air bronchogramsb
Other infiltrate Linear and patchy densities (interstitial infiltrate) in a lacy pattern involving 
both lungs, featuring peribronchial thickening and multiple areas of 
atelectasis; it also includes minor patchy infiltrates that are not of suffi-
cient magnitude to constitute primary endpoint consolidation, and small 
areas of atelectasis which in children may be difficult to distinguish from 
consolidation
Pleural effusion Presence of fluid in the lateral pleural space between the lung and chest 
wall; in most cases, this will be seen at the costophrenic angle or as a 
layer of fluid adjacent to the lateral chest wall; this does not include fluid 
seen in the horizontal or oblique fissures
Uninterpretable Features of the image are not interpretable with respect to presence or 
absence of consolidation and/or other infiltratec
Interpretation process
PERCHd Single arbitrator 4 conclusions Vaccine trial Any abnormality
Conclusions (based on the above findings) Only consolidation or pleural 
effusion without other 
infiltrate
X X
Any consolidation or pleural 
effusion with or without 
other infiltrate
X X
Other infiltrate without 
consolidation
X X X X
Both consolidation and other 
infiltrate
X X
Any consolidation or other 
infiltrate
X
Normal (no consolidation, 
other infiltrate, pleural 
effusion, or uninterpretable 
findings)
X X X X X
Uninterpretable for consolida-
tion and/or other infiltrate
X X X X
Uninterpretable for consolida-
tion onlye
X
Arbitration Arbitration panel or single 
arbitratorf
Panel Single Panel Panel Panel
Abbreviation: PERCH, Pneumonia Etiology Research for Child Health.
a The presence of consolidation or pleural effusion was described in the World Health Organization methodology as “primary endpoint pneumonia” rather than “consolidation” as a specific 
reference to the outcome of interest in bacterial vaccine trials. The descriptive term “consolidation” is preferred in a more general epidemiologic context such as PERCH.
bAtelectasis of an entire lobe that produces an opacity and a positive silhouette sign with the mediastinal border was considered to be consolidation.
cWhere any reader or arbitrator reported a finding of consolidation alongside a finding of uninterpretable for other infiltrate (or vice versa) the interpretation was consolidation (or other infil-
trate). That is, where a pathological finding was reported this was prioritized over an uninterpretable finding when determining the interpretation for the image.
dThis interpretation process was used to define chest radiograph (CXR) outcomes for PERCH cases. Other processes are examined here to illustrate effects of different interpretation 
methods on CXR outcomes.
eFor 64 images where the altered definition of uninterpretable produced discordant interpretations by 2 readers or 2 arbitrators, and no further arbitration interpretations were available, 
conclusions were imputed based on the distribution of conclusions from arbitration of uninterpretable images using the PERCH definitions.
f“Arbitration panel” = where the primary reading resulted in discordant interpretations for any conclusions, the CXR was randomized and independently interpreted by 2 arbitrators. Where 
these arbitrators’ conclusions were discordant, the 2 arbitrators reached agreement through a consensus discussion. Arbitrators were aware of previous conclusions at the final arbitration 
discussion only; “Single arbitrator” = where the primary reading resulted in discordant interpretations for any conclusions, an arbitration decision was sought from a single interpretation 
by the most experienced arbitrator, or by the next most experienced arbitrator when available, or by the third most experienced arbitrator for remaining images. Arbitrators were not aware 
of previous conclusions.
Downloaded from https://academic.oup.com/cid/article-abstract/64/suppl_3/S253/3858215
by London School of Hygiene & Tropical Medicine user
on 26 January 2018
S256 • CID 2017:64 (Suppl 3) • Fancourt et al
RESULTS
Seven (50%) readers passed the standardization assessment 
on the first attempt, 3 on a second attempt, and 4 on a third 
attempt. The voluntary standardization assessment 8  months 
after interpretations began was completed by 11 of 14 readers, 
with intraobserver agreement for the identification of any con-
solidation in the WHO reference CXRs ranging from 85% to 
100% (mean, 91%) and κ values from 0.63 to 1.0 (mean, 0.82).
Of 4232 PERCH cases, 4011 (95%) provided 4172 CXRs, 
with 120 cases providing >1 image. Of the 221 cases without a 
CXR, 92 (42%) were because the child died before a CXR could 
be taken, 23 (10%) had been discharged, 36 (16%) encountered 
equipment or operator errors, and 70 (32%) were for unknown 
reasons.
Observed agreement from the interpretation process is 
summarized in Figure 1. Of the 4172 CXRs reviewed there 
was at least one interpretation of uninterpretable for 675 
(16%) of primary readings and 497 (21%) of arbitration 
readings. Among images without an uninterpretable read-
ing (ie, “interpretable” CXRs), interobserver agreement was 
highest for the detection of any consolidation for both the 
primary reading panel (78% observed agreement; κ = 0.50; 
95% confidence interval [CI], .47–.53) and arbitration panel 
(84%; κ = 0.61; 95% CI, .56–.65; Table 2). The adjusted κ 
for any consolidation was 0.56 and 0.67 for the primary 
and arbitration panels, respectively. There was variation in 
observer agreement for the detection of any consolidation 
between sites; however, much of this variation was not pres-
ent after κ values were adjusted for prevalence and marginal 
distributions (Supplementary Figure 2). Differences between 
observed agreement and κ values were influenced by the 
prevalence of each conclusion more than the different mar-
ginal distributions between readers (Supplementary Table 
3). Considering agreement across all 5 conclusion categories, 
1814 CXRs had a concordant interpretation by the primary 
reading panel (44% observed agreement; κ = 0.25; 95% CI, 
.23–.27). Of 2358 CXRs interpreted by arbitrators (excluding 
quality control images), 1144 had a concordant interpreta-
tion (49%; κ = 0.32; 95% CI, .30–.34). Among 2358 CXRs 
reviewed at arbitration, there was agreement with one of the 
Table 2. Observer Agreement for Individual Conclusions (Present or Absent) for the 14-Member Primary Reading Panel and the 4-Member Arbitration 
Panel, Excluding Images for Which Either Reader/Arbitrator Interpreted as Uninterpretable
Observer Agreement
Primary Readings (n = 3497) Arbitration Readings (n = 1861)a
Conclusion
Observed  
Agreement (%) κ (95% CI) Adjusted κb
Observed  
Agreement (%) κ (95% CI) Adjusted κb
Only consolidation 80.0 0.33 (.30–.37) 0.60 82.5 0.32 (.28–.37) 0.65
Other infiltrate 66.5 0.15 (.12–.18) 0.33 67.8 0.25 (.20–.29) 0.36
Both 80.3 0.21 (.18–.24) 0.61 82.6 0.30 (.25–.34) 0.65
Normal 68.9 0.35 (.32–.38) 0.38 77.1 0.52 (.47–.57) 0.54
Any consolidationc 77.8 0.50 (.47–.53) 0.56 83.6 0.61 (.56–.65) 0.67
 Left 94.8 0.39 (.36–.42) 0.90 92.7 0.42 (.38–.47) 0.85
 Right 82.6 0.46 (.43–.50) 0.65 88.6 0.52 (.48–.57) 0.77
 Bilateral 91.6 0.37 (.34–.40) 0.84 92.2 0.49 (.44–.53) 0.84
Case age, moc
 1–5 76.7 0.49 (.44–.54) 0.53 83.9 0.64 (.57–.72) 0.68
 6–11 78.1 0.52 (.45–.59) 0.56 83.3 0.59 (.50–.69) 0.67
 ≥12 78.8 0.49 (.44–.54) 0.58 83.5 0.57 (.49–.64) 0.67
Equipment and processing techniquec
 Digital 78.5 0.51 (.47–.55) 0.57 84.8 0.62 (.56–.67) 0.70
 Analog 76.0 0.48 (.41–.54) 0.52 80.3 0.58 (.49–.66) 0.61
Time since standardization trainingc,d
 ≤10 mo 81.5 0.59 (.54–.64) 0.63 83.0 0.61 (.52–.70) 0.66
 >10 mo 74.9 0.43 (.38–.47) 0.50 83.8 0.61 (.55–.66) 0.68
Readers’ specialty and years of postspecialization experiencec
 Pediatrics 76.4 0.50 (.45–.55) 0.53 … … … …
 Radiology 83.5 0.53 (.44–.63) 0.67 … … … …
 ≤5 y 76.6 0.48 (.41–.55) 0.53 … … … …
 >5 y 80.0 0.52 (.45–.59) 0.60 … … … …
Abbreviation: CI, confidence interval.
aExcludes 184 quality control images interpreted by arbitrators.
bAdjusted for prevalence and bias [22].
cStratified results are presented for “any consolidation” because this is the primary endpoint of interested under most applications of the World Health Organization methodology.
dTotal time for interpretations by the primary reading panel was 20 months. The arbitration panel did not undergo assessments for standardization but did participate and lead the training process.
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primary readers’ interpretations by one or both arbitrators 
for 1114 (47%) and 930 (40%) CXRs, respectively.
Each of the 14 readers interpreted an average of 598 
images (range, 535–659). Agreement for individual read-
ers was highest for any consolidation (observed agreement 
61%–81%; κ = 0.22–0.60; Figure 2). Considering all 5 con-
clusions, observed agreement for individual readers ranged 
from 30% to 55% (κ = 0.07–0.32). The reader with the lowest 
agreement across these 5 conclusions was an outlier, with 
results (27%; κ = 0.07; 95% CI, .02–.11) significantly lower 
than the reader with the next lowest κ (45%; κ = 0.19; 95% 
CI, .14–.23). These 2 readers with the lowest κ values had 
no prior experience in the WHO methodology and did not 
attend the in-person training. The most frequent type of 
discordance was between normal and other infiltrate, which 
accounted for 743 of 2358 (32%) CXRs discordant at the pri-
mary interpretation and 360 of 1214 (30%) CXRs discordant 
at arbitration (Table 3).
The 4 arbitrators interpreted an average of 1179 images 
(range, 1175–1187). Of these interpretations, 561–647 (range, 
48%–55%) were discordant with the other arbitrator. We 
expected that each arbitrator would have an equal proportion 
(25%) of all consensus discussion conclusions agree with their 
initial interpretation; however, one arbitrator had a lower pro-
portion (15%) and one a higher proportion (34%, P < .0001). 
The final arbitration discussion conclusion was different from 
both arbitrators’ initial interpretations for 89 of 1214 (7%) 
CXRs.
The arbitration panel reviewed 184 CXRs for quality control. 
Of the 44 CXRs concordant for any consolidation at the pri-
mary reading panel, there was agreement on this conclusion 
by both arbitrators for 30 (68%) CXRs and agreement by at 
least one arbitrator for 41 (93%; Table 4). Across all 5 conclu-
sions, there was concordance between arbitrators for 102 (55%) 
images and, of these, 83 (81%) had the same conclusion as the 
primary reading panel. After final arbitration discussions, there 
was concordance between the conclusion of the readers and 
arbitrators in 129 of the 184 CXRs (70%).
We evaluated 4 different interpretation processes that had 
alternate conclusions or arbitration methods and assessed their 
effect on the distribution of conclusions, observer agreement, 
and total number of interpretations compared to the PERCH 
interpretation process (Table 5). The process used in the vaccine 
trials [23], which considered images discordant between other 
infiltrate/normal or other infiltrate/uninterpretable as other 
infiltrate (ie, no arbitration), resulted in 23% of images with final 
conclusions different from those obtained under the PERCH 
process. As expected, this process also identified the highest 
proportion of images with other infiltrate (39% vs 24% using the 
PERCH process). Although a process using a single arbitration 
interpretation produced a similar distribution of conclusions to 
the PERCH process, 16% of CXRs had a different conclusion. 
Using a majority decision from the primary reading interpreta-
tions and that of a single arbitrator left 480 of 4172 (12%) CXRs 
without a conclusion under the PERCH process and 226 (5%) 
without a conclusion under the vaccine trial process (data not 
shown). The various processes also required different total num-
bers of interpretations; the PERCH process required the most, 
while the single arbitration process and the vaccine trial process 
required 25% and 24% fewer interpretations, respectively.
Figure 2. Observer agreement for individual readers for the finding of any con-
solidation, excluding images for which either reader concluded as uninterpretable 
(range, 440–568).
Table 3. Summary of Discordant and Concordant Conclusions for Either the 2 Randomly Assigned Readers or the 2 Randomly Assigned Arbitrators
Discordant Conclusionsa, No. (Row %)
Normal/ 
Infiltrate
Infiltrate/ 
Consol.
Normal/ 
Consol.
Consol./ 
Uninterp.
Both/  
Consol.
Both/ 
Infiltrate
Both/  
Normal
Both/ 
Uninterp.
Normal/ 
Uninterp.
Infiltrate/ 
Uninterp. Totalb
Readers 743 (31.5) 198 (8.4) 196 (8.3) 126 (5.3) 306 (13.0) 232 (9.8) 149 (6.3) 47 (2.0) 264 (11.2) 97 (4.1) 2358
Arbitrators 360 (29.7) 108 (8.9) 46 (3.8) 62 (5.1) 171 (14.1) 130 (10.7) 21 (1.7) 23 (1.9) 181 (14.9) 112 (9.2) 1214
Concordant Conclusions, No. (Row %)
Consol. Infiltrate Both Normal Uninterp. Totalb
Readers 294 (16.2) 361 (19.9) 164 (9.0) 854 (47.1) 141 (7.8) 1814
Arbitrators 121 (10.6) 276 (24.1) 107 (9.4) 521 (45.5) 119 (10.4) 1144
aBoth, consolidation and other infiltrate; Consol., consolidation; Infiltrate, other infiltrate; Uninterp., uninterpretable. 
bAmong arbitrators, excludes 184 quality control images.
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DISCUSSION
This study is the largest published evaluation of the WHO meth-
odology, and one of few studies where standardization has been 
attempted across multiple sites with different epidemiological 
characteristics. Achieving standardization is important to pro-
vide confidence in the use of CXR results, including the inter-
pretation of pneumonia etiology. Our results show measures 
of observer agreement for the detection of any consolidation 
that are consistent with other high-quality studies of childhood 
pneumonia [9, 13, 24], and similar to other subjective diagnos-
tic tests, such as cervical cytopathology [25] and prostatic histo-
pathology [26]. Our experience reaffirms findings that observer 
agreement is best for consolidation and poorest for findings of 
other infiltrate [3, 27]. The interpretation of observer variability 
requires consideration of study-specific factors that can influ-
ence κ, such as the prevalence of the conclusion under evalu-
ation. Detailed understanding of the core components of the 
CXR interpretation process informs wider PERCH analyses and 
the transition of the WHO methodology from vaccine trials to 
other epidemiological contexts.
Standardized interpretation of CXRs is important to ensure 
that differences between sites or across time are not due to dif-
ferences in CXR interpretation but to differences in the case mix 
of enrolled children. We minimized bias by ensuring readers 
did not interpret CXRs from their own site. This is important 
for a multisite study like PERCH, as comparisons by site will be 
central to some analyses. Our structured training process aimed 
to achieve a common standard of interpretation with the WHO 
methodology, calibrated to CXRs from the PERCH study. 
Although readers did not have to correctly interpret 100% of 
test images to be eligible to interpret PERCH CXRs, the require-
ments were pragmatic but robust, with several readers requir-
ing repeated attempts to pass. However, our ability to evaluate 
whether the training itself actually improved individual ability 
was limited because there were no pretraining assessments and 
the number of images interpreted for assessments was small. 
Observer agreement for the primary reading panel declined 
between the first and second halves of the interpretation pro-
cess, suggesting the readers had increasing difficulty in apply-
ing the interpretation criteria. Future studies may benefit from 
continuing education and regular standardization assessments.
The WHO methodology was designed to optimize the detec-
tion of any consolidation (termed primary endpoint pneumonia 
for the vaccine trials), and this conclusion had the highest level 
of agreement in our study, similar to other pneumonia stud-
ies [9, 13, 23, 24] and evaluations of the WHO methodology 
Table 4. Results of the Quality Control Process (Arbitration of a Random Selection of 10% Concordant Images for Each Conclusion from the Primary 
Reading)
Arbitrators’ Conclusions, No. (Row %)
Readers’ 
Conclusion
Both Agree  
With Readers
One Agrees &  
One Disagrees  
With Readers
Both Disagree  
With Readers Total
Only consolidation
 Yes 11 (37.9) 12 (41.4) 6 (20.7) 29
 No 2 (1.3) 15 (9.7) 138 (89.0) 155
 Total 13 27 144 184
Other infiltrate
 Yes 9 (25.7) 17 (48.6) 9 (25.7) 35
 No 3 (2.0) 26 (17.4) 120 (80.5) 149
 Total 12 43 129 184
Both
 Yes 2 (13.3) 9 (60.0) 4 (26.7) 15
 No 4 (2.4) 12 (7.1) 153 (90.5) 169
 Total 6 21 157 184
Normal
 Yes 52 (60.5) 26 (30.2) 8 (9.3) 86
 No 8 (8.2) 20 (20.4) 70 (71.4) 98
 Total 60 46 78 184
Uninterpretable
 Yes 9 (47.4) 5 (26.3) 5 (26.3) 19
 No 2 (1.2) 22 (13.3) 141 (85.5) 165
 Total 11 27 146 184
Any consolidation
 Yes 30 (68.2) 11 (25.0) 3 (6.8) 44
 No 4 (2.9) 7 (5.0) 129 (92.1) 140
 Total 34 18 132 184
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[3, 27]. Interobserver agreement for any consolidation in both 
the Californian and Gambian pneumococcal conjugate vac-
cine (PCV) trials was κ = 0.58 (data was not reported for other 
trials) [9, 23]. Similarly, a Mozambique pneumonia incidence 
study had an agreement of 77% (κ = 0.52) for any consolidation 
[13]. In an antibiotic treatment study in Brazil, agreement for 
the detection of any consolidation or other infiltrate was 87% 
(κ = 0.68). This higher κ likely reflects a case mix with a higher 
prevalence of consolidation because of an enrollment criterion 
requiring the presence of CXR infiltrates [24].
Relying solely on consolidation may underestimate bur-
den of disease [28], as suggested by estimates from the South 
African PCV trial where only 38% of children with pneumococ-
cal pneumonia were thought to have CXR consolidation [29]. 
While study methods and case selection criteria can influence 
prevalence estimates of consolidation [23, 30], PERCH used a 
rigorously standardized study protocol and demonstrated a var-
ied prevalence between sites [31]. Other radiographic appear-
ances also capture cases of true pneumonia, pneumococcal or 
otherwise. Unfortunately, agreement on the presence of other 
infiltrates is more difficult to achieve [3, 27]; our results show 
lowest agreement for a finding of other infiltrate (Table 2) and 
that discordance is most common between interpretations 
of normal and other infiltrate (Table 3). The limitation of the 
WHO methodology in identifying nonconsolidation findings 
is particularly important in contexts where the prevalence of 
consolidation is low and milder radiographic changes predom-
inate, such as areas with access to early antibiotic therapy or 
widespread use of pneumococcal and Hib conjugate vaccines.
Despite some consistency between studies in observer agree-
ment for any consolidation, it can be misleading to compare κ 
values without reference to differences in the prevalence of the 
conclusion under evaluation [22]. This can arise when compar-
ing results for different CXR definition categories or between 
epidemiological contexts. We observed the paradox of preva-
lence unexpectedly altering κ values for any consolidation and 
only consolidation where approximately 80% agreement was 
observed for both but κ was 0.50 and 0.33, respectively, owing to 
the prevalence of any consolidation being closer to 50% (Table 2 
and Supplementary Table 3). A paradoxically high κ can also be 
produced if the readers conclude a different proportion of posi-
tive findings, although we did not observe this (Supplementary 
Table 3). Nonetheless, examining differences in marginal pro-
portions offers an important check to demonstrate the inter-
changeability of readers [22], particularly for a large panel of 
readers from different regions with a range of professional expe-
rience. Agreement will also decrease as the number of conclu-
sion categories increases, explaining why agreement was higher 
for the any abnormality interpretation process (which had 3 
conclusion categories) than the PERCH interpretation process 
(which had 5 conclusion categories; Table 4). Despite this, our 
results show consistency in the proportion of any consolidation 
Table 5. Comparison of Pneumonia Etiology Research for Child Health (PERCH) Study and Alternate Processes for Chest Radiographic Interpretation 
(Includes Multiple Images on 120 Cases)
Conclusionsa, No. (%) Agreement, % (κ) Total
Interpretation 
Process
Only 
Consol.
Other 
Infiltrate Both Uninterp. Normal Any Consol. Abnormal
Conclusion 
Changed Readers Arbitrators
No. of 
Readings 
(% Difference)
All 4172 CXRs
PERCHb 611 (14.7) 993 (23.8) 464 (11.1) 412 (9.9) 1692 (40.6) 1075 (25.8) 2068 (49.6) Ref 43.5 (0.25) 48.5 (0.32) 
n = 2358
14 274 (Ref)
Single arbitrationc 638 (15.3) 979 (23.5) 414 (9.9) 488 (11.7) 1653 (39.6) 1052 (25.2) 2028 (48.6) 680 (16.3) 43.5 (0.25) … 10 702 (25.0)
4 conclusionsd … 950 (22.8) … 398 (9.5) 1684 (40.4) 1140 (27.3) 2090 (50.1) 65 (1.6) 50.8 (0.31) 52.8 (0.33) 
n = 2052
13 417 (6.0)
Vaccine triale … 1615 (38.7) … 155 (3.7) 1330 (31.9) 1072 (25.7) 2687 (64.4) 938 (22.5) 53.2 (0.32) 52.2 (0.34) 
n = 1113
10 866 (23.9)
Any abnormalityf … … … 376 (9.0) 1612 (38.6) … 2184 (52.4) 116 (2.8) 61.1 (0.32) 60.0 (0.35) 
n = 1622
12 237 (14.3)
Abbreviations: CXR, chest radiograph; PERCH, Pneumonia Etiology Research for Child Health.
aBoth, consolidation and other infiltrate; Consol., Consolidation; Uninterp., Uninterpretable. “Any consolidation” combines images concluded as “only consolidation” or “both consolidation 
and other infiltrate”; “Abnormal” combines images concluded as only consolidation,” “other infiltrate,” or “both”; “Conclusion changed” compares to PERCH process results, reclassified to 
the conclusion categories of the comparison process where necessary.
bFive conclusions (consolidation only, other infiltrate only, both consolidation and other infiltrate, normal, uninterpretable for consolidation and/or other infiltrate); 2 arbitrators; final arbitration 
discussion.
cFive conclusions (consolidation only, other infiltrate only, both consolidation and other infiltrate, normal, uninterpretable for consolidation and other infiltrate); single arbitration from the most 
experienced arbitrator when available, or from the next most experienced arbitrator when available, or from the third most experienced arbitrator for remaining images.
dFour conclusions (any consolidation, other infiltrate only, normal, uninterpretable for consolidation and/or other infiltrate); 2 arbitrators; final arbitration discussion.
eFour conclusions (any consolidation, other infiltrate only, normal, uninterpretable for consolidation only); disagreement between other infiltrate and normal, or other infiltrate and uninterpre-
table, is concluded as positive for other infiltrate; 2 arbitrators; final arbitration discussion. For 64 images where the altered definition of uninterpretable produced discordant interpretations 
by 2 readers or 2 arbitrators, and no further arbitration interpretations were available, conclusions were imputed based on the distribution of conclusions from arbitration of uninterpretable 
images using the PERCH definitions.
fThree conclusions (any consolidation and/or other infiltrate, normal, uninterpretable for consolidation and/or other infiltrate); 2 arbitrators; final arbitration discussion.
Downloaded from https://academic.oup.com/cid/article-abstract/64/suppl_3/S253/3858215
by London School of Hygiene & Tropical Medicine user
on 26 January 2018
S260 • CID 2017:64 (Suppl 3) • Fancourt et al
(range, 25%–27%) identified by 4 different interpretation pro-
cesses (Table 4).
Determining the “best” method for arbitration depends on 
the desire to maximize accuracy of interpretation of pneumo-
nia cases within the study, the ability to standardize methods 
across studies to facilitate between-study comparisons, and 
financial and logistical constraints. Use of a separate, com-
mon, arbitration panel was established in the WHO method-
ology [2] and adopted for vaccine trials [7, 8, 11, 32] to ensure 
consistency between studies. Using arbitrators with extensive 
experience in the WHO methodology is favored over a con-
sensus discussion between primary readers because the former 
are assumed to have higher agreement on arbitration images, 
which are the most difficult to interpret. While a process with 
a single arbitrator may be necessary in studies with logistical 
constraints, this is not favored because variability among arbi-
trators means reproducibility between studies may be limited.
We found that a majority of CXRs at arbitration required 
consensus discussion to reach a final conclusion, which likely 
reflects the complexity of those CXRs. While initial blinded 
review by 2 arbitrators before a final discussion necessitates 
additional interpretations, feedback from our arbitrators sug-
gests this may not be an increased workload compared to a 
discussion alone. Therefore, initial blinded review by 2 arbi-
trators followed by consensus discussion for discordant images 
appears to be an effective method to resolve the interpretation 
of CXRs that are discordant at the primary reading. Because 
we observed differences in the proportion of conclusions from 
consensus discussions that agreed with each arbitrators’ initial 
conclusions, future studies may benefit from ensuring these dis-
cussions are blinded to previous interpretations.
The PERCH study is the largest evaluation of the WHO meth-
odology for the standardized interpretation of pediatric CXRs. 
Our results reinforce the reproducibility for detecting consoli-
dation and the failure to achieve equally high concordance on 
other conclusions, including distinguishing normal from other 
infiltrates. The misclassification between these categories must 
be acknowledged in the analyses drawn from studies that use 
CXR findings. While limiting the number of final conclusion 
categories will improve observer agreement, the conclusion 
definition is the primary influence on agreement. Furthermore, 
resolving conclusions of discordant CXRs at primary reading 
should be done through additional independent arbitration 
readings, with any further discordance resolved through con-
sensus discussion blinded to previous interpretations. Finally, 
the training process, quality control process, algorithm for draw-
ing final conclusions, and the effect of prevalence on observer 
agreement all influence study results and need to be reported 
in detail so that any cross-study comparisons take these dif-
ferences into consideration. Chest imaging continues to be an 
important element of pneumonia epidemiologic research, and 
efforts to improve image interpretation and observer variability, 
including use of computer-aided detection or other imaging 
techniques such as ultrasound, warrant additional evaluation.
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